This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patientcare activities. Community pharmacies, as trusted vaccination providers, must stay informed about ACIP proceedings and public discussions to address emerging patient inquiries effectively.
In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patientcare.
SHOW MORE The injection is indicated for the treatment of sepsis and other serious infections, enhancing treatment efficiency and patientcare. The injection's room-temperature stability and compatibility with automated dispensing cabinets facilitate integration into hospital workflows.
Dave’s Pharmacy in Nebraska was recognized for its innovative patientcare, winning Pharmacy of the Year. The conference highlighted expanding pharmacists' roles, diversifying services, and addressing health care access gaps.
Coming to meetings and hearing these great presenters in different areas really connects with different parts of my history of patientcare. I'm blown away by how quickly new information is brought to this conference and how well the teams break it into actionable insights you can bring back to your patientcare.
Beyond that, it’s about sharing clinical experiences—learning how others approach patientcare, maybe doing things a little differently or more effectively. It’s incredibly impactful to be in a room full of amazing pharmacists from across the country, reviewing late-breaking ASCO data.
That does allow the pharmacist to provide care to the community, but you have to find a physician willing to countersign that, willing to delegate that authority, and therein lies the barrier.” Overall, CPAs in areas lacking certain pillars of health care can improve the efficiency and quality of patientcare.
By meticulously reviewing medication regimens, reconciling discrepancies, and providing comprehensive education to patients and caregivers, they significantly reduce the likelihood of medication errors and adverse drug events during these vulnerable periods. 2 REFERENCES 1.
Isaacs stresses the critical role of pharmacists in staying informed about these advancements, recommending strategies like attending the conference, accessing virtual options, and sharing new findings through methods like journal clubs to improve patientcare. Pharmacy Times: Can you introduce yourself?
In an interview with Pharmacy Times , LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, oncology clinical manager at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina, shares insights about the facility’s Wake Outpatient Transplant Program and highlights its positive impact on patientcare outcomes.
The FDA approval process for biologics is lengthier compared with biosimilars. The process can take about 10 to 15 years and consist of preclinical studies in which the drug is “discovered,” submission of an investigational new drug application, first-in-human trials, and other phase trials.
Misconceptions can lead to unnecessary hesitation, increased health care spending, and reduced access to important biologic treatments. Image credit: Shutter2U | stock.adobe.com Biosimilars are biologic products highly similar to an FDA-approved reference product, with no clinically meaningful differences in safety, purity, or potency.
Evidence supports the model's effectiveness, showing reduced relapse rates in multiple sclerosis patients. SHOW MORE Integrating specialty pharmacists into neurology teams enhances patientcare, medication management, and clinical outcomes for chronic conditions.
Pharmacists are essential in managing access, patient education, and monitoring outcomes, ensuring adherence and addressing administrative challenges. SHOW MORE Discover how Vyepti revolutionizes migraine prevention with rapid efficacy and strong safety, empowering pharmacists to enhance patientcare.
Kalis, PharmD, BCOP Key Takeaways Oncology pharmacy's complexity outpaces the generalist model, necessitating specialization for effective patientcare and operational efficiency. High attrition rates in oncology pharmacy highlight the unsustainable burden of maintaining expertise across all cancer types and treatments.
Meloxicam injection (Xifyrm; Azurity Pharmaceuticals, Inc) received FDA approval for use in adults for the management of moderate-to-severe pain, either alone or in combination with non-steroidal anti-inflammatory drug (NSAID) analgesics.
Their goal was to promote consistent, high-quality, pharmacist-led care by standardizing the way clinical competence is evaluated—both at initial onboarding and as part of ongoing professional development. Using a roadmap strategy, the team established milestones and recruited expert pharmacists involved directly in CPA-driven patientcare.
A study of 439 patient charts found no significant difference in DTP identification between clinics with and without pharmacists on the care team. The integration of community-based specialty pharmacists into patientcare models is crucial for enhancing treatment safety and efficacy.
2 Despite its widespread acceptance, an FDA-led clinical trial unexpectedly found that even a low-dose CBD regimen led to clinically meaningful liver enzyme elevations in 5.6% of healthy volunteers—effects that resolved after discontinuation.
All graduates should be ready for this, as our present Accreditation Council for Pharmacy Education Standards explicitly states: "Ensure that graduating students are ‘practice-ready’ and ‘team-ready,’ that is, prepared to directly contribute to patientcare working in collaboration with other health care providers."
TRE-515 aims to extend patient lives and elevate current standards of care by combining radioligand therapy with novel drug approaches. SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patientcare.
The authors examined the safety, feasibility, and toxicity management of delivering both SUD and target doses in outpatient settings, offering institutional guidance for optimizing patientcare and reducing hospitalization burden.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patientcare, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy.
A medication shortage occurs when the demand for a drug is greater than the supply, according to the Food and Drug Administration (FDA). The FDA tracks drug shortages at the national level by obtaining information from drug manufacturers about their ability to produce medications. Many factors cause medication shortages.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content